市場調査レポート

商品コード

1593443

自動注射器市場規模、シェア、成長分析、用途別、技術別、投与経路別、治療領域別、容量別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Auto injector Market Size, Share, Growth Analysis, By Usage, By Technology, By Route of Administration, By Therapy Area, By Volume, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年11月13日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

自動注射器の世界市場規模は2022年に71億6,000万米ドルと評価され、2023年の83億7,000万米ドルから2031年には245億9,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは14.42％で成長する見通しです。

世界の自動注射器市場は、慢性疾患の罹患率の上昇、自己投与装置に対する需要の高まり、継続的な技術の進歩など、いくつかの重要な要因によって力強い成長を遂げています。自動注射器は、アレルギー反応用のエピネフリンや糖尿病管理用のインスリンなどの薬剤の正確な送達を容易にし、ユーザーフレンドリーな操作、正確な投与、治療プロトコルの患者のアドヒアランス向上などの大きな利点を提供します。同市場の注目すべきプレーヤーには、製薬会社、医療機器メーカー、技術革新企業が含まれ、各社はデザイン、安全性、多様な薬剤への対応能力といった製品特性に重点を置いて市場シェアを争っています。さらに、規制の枠組み、償還政策、特許保護といった重要な市場力学が、競合情勢の形成に重要な役割を果たしています。特に米国の自動注射器市場は、ヘルスケア環境におけるこれらの機器の受け入れ拡大を反映して、今後数年間は持続的な年間平均成長率（CAGR）を維持すると予測されています。この拡大は、自動注射器が効果的な疾患管理に不可欠なツールとして認知されつつあることを強調するものであり、最終的には治療結果の改善とヘルスケアルーチンの自律化を通じて患者に利益をもたらします。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

SHL Medical AG
Ypsomed AG
Becton, Dickinson and Company（BD）
EQT IX（Recipharm AB）
West Pharmaceutical Services, Inc.
Molex（Phillips-Medisize）
Halozyme, Inc.
Owen Mumford Ltd.
AbbVie Inc.
Amgen Inc.
Novo Holdings A/S
Johnson & Johnson
Sanofi
GSK PLC
Gerresheimer AG
Medmix（Haselmaier）
SMC Ltd.（Oval Medical Technologies Ltd.）
Kaleo, Inc.
Solteam Incorporation Co., Ltd.
Elcam Drug Delivery Devices
Crossject
Jabil Inc.
Congruence Medical Solutions LLC
Midas Pharma GmbH

Product Code: SQMIG35B2104

Global Autoinjectors Market size was valued at USD 7.16 billion in 2022 and is poised to grow from USD 8.37 billion in 2023 to USD 24.59 billion by 2031, growing at a CAGR of 14.42% during the forecast period (2024-2031).

The global auto injector market is witnessing robust growth driven by several key factors, including the rising incidence of chronic diseases, an elevated demand for self-administration devices, and ongoing technological advancements. Auto injectors, which facilitate the precise delivery of medications such as epinephrine for allergic reactions and insulin for diabetes management, provide significant advantages including user-friendly operation, accurate dosing, and enhanced patient adherence to treatment protocols. Notable players in the market encompass pharmaceutical firms, medical device manufacturers, and technology innovators, who vie for market share by focusing on product attributes like design, safety, and the ability to accommodate diverse medications. Additionally, crucial market dynamics-such as regulatory frameworks, reimbursement policies, and patent protections-play a significant role in shaping the competitive landscape. In particular, the U.S. auto injector market is forecasted to maintain a sustainable compound annual growth rate (CAGR) in the upcoming years, reflecting a growing acceptance of these devices in healthcare settings. This expansion underscores the increasing recognition of auto injectors as essential tools for effective disease management, ultimately benefiting patients through improved therapeutic outcomes and autonomy in their healthcare routines.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Autoinjectors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Autoinjectors Market Segmental Analysis

Global Autoinjectors Market is segmented by Usage, Technology, Route of Administration, Therapy Area, Volume, End User and Region. Based on Usage, the market is segmented into Disposable Autoinjectors, Reusable Autoinjectors. Based on Technology, the market is segmented into Manual Autoinjectors, Automatic Autoinjectors. Based on Route of Administration, the market is segmented into Subcutaneous, Intramuscular, Intravenous. Based on Therapy Area, the market is segmented into Rheumatoid Arthritis, Diabetes, Multiple Sclerosis, Anaphylaxis, Obesity, Other Therapy Areas. Based on Volume, the market is segmented into Up To 3ml, and Above 3ml. Based on End User, the market is segmented into Home Care Settings, Hospitals & Clinics, Ambulatory Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Autoinjectors Market

The rising incidence of chronic diseases, including rheumatoid arthritis, multiple sclerosis, diabetes, and allergies, serves as a pivotal market driver for the global autoinjectors market. As these conditions become increasingly prevalent, the demand for self-administration of medications is accelerating, highlighting the convenience and efficiency that autoinjectors provide. These devices empower patients, allowing for timely and accurate medication delivery, thereby enhancing treatment adherence and overall health outcomes. Moreover, the technological advancements in autoinjectors-such as needle safety features and user-friendly designs-further bolster their appeal, positioning them as essential tools for chronic disease management in an ever-evolving healthcare landscape.

Restraints in the Global Autoinjectors Market

The high cost of autoinjector devices serves as a significant market restraint, especially in emerging economies where access to healthcare solutions is often dictated by affordability. Patients in these regions may find the price point of autoinjectors prohibitive, leading to reluctance in adoption compared to more traditional and economically viable alternatives like syringes. This disparity not only limits the market potential for autoinjector manufacturers but also poses challenges for healthcare providers seeking to implement innovative treatment options. Consequently, the financial barrier associated with these advanced delivery systems can impede market growth and patient access, hindering the overall expansion of the global autoinjectors market.

Market Trends of the Global Autoinjectors Market

The Global Autoinjectors market is experiencing a significant trend towards self-administration of medications, driven by a growing patient preference for autonomy and convenience in treatment management. As patients increasingly seek to take control of their healthcare, the adoption of autoinjectors is on the rise, offering an efficient and user-friendly means to administer medications accurately. This empowerment fosters adherence to treatment regimens and enhances patient satisfaction. Furthermore, advancements in technology and design, coupled with an expanding range of therapies requiring autoinjectors, are anticipated to propel market growth, making it a pivotal segment in the broader healthcare landscape.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Supply Chain Analysis
Technology Analysis
Patent Analysis
Pricing Analysis
Trade Analysis
Customer & Buying Criteria Analysis
Regulatory landscape

Auto injector Market, By Usage

Market Overview
Disposable Autoinjectors
Reusable Autoinjectors

Auto injector Market, By Technology

Market Overview
Manual Autoinjectors
Automatic Autoinjectors

Auto injector Market, By Route Of Administration

Market Overview
Subcutaneous
Intramuscular
Intravenous

Auto injector Market, By Therapy Area

Market Overview
Rheumatoid Arthritis
Diabetes
Multiple Sclerosis
Anaphylaxis
Obesity
Other Therapy Areas

Auto injector Market, By Volume

Market Overview
Up To 3ml
Above 3ml

Auto injector Market, By End User

Market Overview
Home Care Settings
Hospitals & Clinics
Ambulatory Care Settings

Auto injector Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

SHL Medical AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EQT IX (Recipharm AB)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
West Pharmaceutical Services, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molex (Phillips-Medisize)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Halozyme, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Owen Mumford Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Holdings A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GSK PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gerresheimer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medmix (Haselmaier)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SMC Ltd. (Oval Medical Technologies Ltd.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaleo, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Solteam Incorporation Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elcam Drug Delivery Devices
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Crossject
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jabil Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Congruence Medical Solutions LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Midas Pharma GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

自動注射器市場規模、シェア、成長分析、用途別、技術別、投与経路別、治療領域別、容量別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Auto injector Market Size, Share, Growth Analysis, By Usage, By Technology, By Route of Administration, By Therapy Area, By Volume, By End User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

自動注射器市場：用途別

自動注射器市場：技術別

自動注射器市場：投与経路別

自動注射器市場：治療領域別

自動注射器市場：容量別

自動注射器市場：エンドユーザー別

自動注射器市場：地域別